Clinical Trial Update: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old [Phase 4]

View source ↗

Summary

Open-label Phase 4 study of lurasidone (Latuda) for mania in youths aged 6-17 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder
• Bipolar Spectrum Disorder
• Mania

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Mania, Bipolar I | Phase 4 | Status: WITHDRAWN